Robenacoxib
Based on 1 Customer Validation
Robenacoxib is a nonsteroidal anti-inflammatory and analgesic agent. Robenacoxib is a selective COX-2 inhibitor.
For research use only. We do not sell to patients.
- Purity : 98.08%
- CAS No.: 220991-32-2
- Formula: C16H13F4NO2
- Molecular Weight:327.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B0386
Flunixin meglumineCOX Inhibitor -
HY-100516
CimicoxibCOX-2 Inhibitor -
HY-115866
COX-2-IN-6COX Inhibitor -
HY-B0493
Niflumic acidChloride Channel/COX Inhibitor -
HY-118078R
Robenacoxib (Standard)COX-2 Inhibitor -
HY-100516R
Cimicoxib (Standard)COX-2 Inhibitor -
HY-B0578A
Loxoprofen sodiumAnti-Inflammatory Agent -
HY-B1452
LicofeloneCOX/5-LOX Inhibitor -
HY-B0493R
Niflumic acid (Standard)Chloride Channel/COX Inhibitor -
HY-112731
TFAPCOX-1 Inhibitor -
HY-B0386R
Flunixin meglumine (Standard)COX Inhibitor -
HY-103387
DuP-697COX-2 Inhibitor
Biological Activity
Description
Chemical Information
-
CAS No. 220991-32-2
-
Appearance Solid
-
Molecular Weight 327.27
-
Formula C16H13F4NO2
-
Color Off-white to light yellow
-
SMILES
O=C(CC1=CC(CC)=CC=C1NC2=C(C(F)=CC(F)=C2F)F)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
In Vitro:
DMSO : 125 mg/mL (381.95 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (701 KB)
- English - EN (701 KB)
- Français - FR (701 KB)
- Deutsch - DE (701 KB)
- Norwegian - NO (701 KB)
- Español - ES (701 KB)
- Swedish - SV (701 KB)
- Italian - IT (701 KB)
- Korean - KR (701 KB)
- Portuguese - PT (701 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kongara K, et al. Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med (Auckl). 2018 Aug 15;9:53-61. [Content Brief]
[2]. Schmid VB, et al. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. J Vet Pharmacol Ther. 2010 Apr;33(2):118-31. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.0556 mL | 15.2779 mL | 30.5558 mL | 76.3895 mL |
| 5 mM | 0.6111 mL | 3.0556 mL | 6.1112 mL | 15.2779 mL | |
| 10 mM | 0.3056 mL | 1.5278 mL | 3.0556 mL | 7.6390 mL | |
| 15 mM | 0.2037 mL | 1.0185 mL | 2.0371 mL | 5.0926 mL | |
| 20 mM | 0.1528 mL | 0.7639 mL | 1.5278 mL | 3.8195 mL | |
| 25 mM | 0.1222 mL | 0.6111 mL | 1.2222 mL | 3.0556 mL | |
| 30 mM | 0.1019 mL | 0.5093 mL | 1.0185 mL | 2.5463 mL | |
| 40 mM | 0.0764 mL | 0.3819 mL | 0.7639 mL | 1.9097 mL | |
| 50 mM | 0.0611 mL | 0.3056 mL | 0.6111 mL | 1.5278 mL | |
| 60 mM | 0.0509 mL | 0.2546 mL | 0.5093 mL | 1.2732 mL | |
| 80 mM | 0.0382 mL | 0.1910 mL | 0.3819 mL | 0.9549 mL | |
| 100 mM | 0.0306 mL | 0.1528 mL | 0.3056 mL | 0.7639 mL |
Robenacoxib Related Classifications
HY-118078 Related Classifications
Powered by Bioz